Fibrinogenolytic properties of natrahagin (a proteinase from cobra venom) and its effect on human platelet aggregation

Acta Pharmacologica Sinica

Volumn 20, Issue 10, 1999, Pages 944-947

  Zhu, Zheng Guang ^a   Wu, Shu Guang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Cobra venoms; Platelet aggregation; Platelet membrane glycoproteins; Protein glutamine gamma glutamyltransferase; Ristocetin; Thrombin

Indexed keywords

FIBRINOGEN RECEPTOR; NATRAHAGIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEINASE; SNAKE VENOM; THROMBIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; FIBRINOGENOLYSIS; HUMAN; MALE; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

ADULT; COBRA VENOMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FIBRINOGEN; FIBRINOLYTIC AGENTS; HUMANS; MALE; METALLOENDOPEPTIDASES; PHENOBARBITAL; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; QUINIDINE;

EID: 0032746270     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Ouyang C, Teng CM, Huang TF. Charaterization of snake venom components acting on blood coagulation and platelet function. Texicon 1992; 30: 945-966.
2. Fen Y, Tan H, Lui ZL, Yu QS, Guan JX. Experimental study on the antithrombotic effect of cobra venom. Acad J Guangzhou Med Coll 1996; 24: 9-12.
3. Ward CM, Andrews RK, Ian Smith A, Berndt MC. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand Factor receptor glycoprotein Ibα. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibα as a binding site for von Willebrand Factor and α-thrombin. Biochemistry 1996; 35: 4929-38.
4. Evans JH. Purification and properties of a fibrinogenase from the venom of Naja nigricollis. Biochim Biophys Acta 1984; 802: 49-54.
5. Kini RM, Evans HJ. Inhibition of platelet aggregation by a fibrinogenase from Naja nigricollis venom is independent of fibriongen degradation. Biochim Biophys Acta 1991; 1095: 117-21.
6. De Luca M, Dunlop LC, Andrews RK, Flannery JV Jr, Ettling R, Cumming DA, et al. A novel cobra venom metalloproteinase, mocarhagin, cleaves a 10-amino acid peptide from the mature N terminus of P-selectin glycoprotein ligand receptor, PSGL-1, and abolishes P-selectin binding. J Biol Chem 1995; 270: 26734-7.
7. Huang TF, Chang MC, Peng HC, Teng CM. A novel α-type fibrinogenase from Agkistrodon rhodostoma snake venom. Biochim Biophys Acta 1992; 1160: 262-8.
8. Kamiguti AS, Slupsky JR, Zuzel M, Hay CRM. Properties of fibrinogen cleaved by jarahagin, a metalloproteinase from the venom of Bothrops jararaca. Thromb Haemost 1994; 72: 244-9.
9. Ruggeri ZM. von Willebrand factor. J Clin Invest 1997; 99: 559-64.
10. Kamiguti AS, Hay CRM, David R, Theakston G, Zuzel M. Insights into the mechanism of haemorrhage caused by snake venom metalloproteinases. Toxicon 1996; 34: 627-42.